ckd glp-1 for Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and RAs Frontiers Kidney-Protection Benefits of Metabolic Surgery

Lind M, et al

From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonists Dual Role in Prostate Cancer. Cancers, 16*(1538)

Pairing this one-month $199 Wegovy offer to new patients with Ro's lowered membership fee is another proof point of how we're working to reduce the cost barrier for more patients to begin their obesity care journey," said Dave Moore, Executive Vice President, U.S

doi: 10.3389/fmedt.2025.1654003 Received 25 June 2025 Accepted 20 October 2025 Published 20 November 2025 Volume 7 - 2025 Edited by Barkha Yadav-Samudrala, University of North Carolina at Chapel Hill, United States Reviewed by Sadanand Pandey, Yeungnam University, Republic of Korea Deepak Kumar Tripathi, University of Colorado Anschutz Medical Campus, United States Updates Copyright 2025 Kumar, Sharma and Singh

[PMID: 42152320] PubMed record related to this compound for laboratory literature review